baber/WOPTO huggingface dataset:
Patent NZ-553754-A (NZ)
Title: Wafer lock cylinder with open ended key receiving slot in wafer and abutment to prevent wafer falling out of cylinder
Inventor: HOPE ROBERT EDWARD
IPC: E05B23/00
Filed: 2007-03-12
Abstract: Disclosed is an improvement/modification to what is disclosed in the complete specification of patent application 326495. In order to retain the wafer locks from falling out during assembly of a lock an engagement surface 25 is provided to engage an abutment surface 27 on the inside of the lock cylinder. (61) Addition to 553754
Patent NZ-554041-A (NZ)
Title: Novel pyridinone derivatives and their use as positive allosteric modulators of MGLUR2-receptors
Inventor: IMOGAI HASSAN JULIEN
IPC: C07D217/24
Filed: 2005-09-16
Abstract: Disclosed is a compound of formula (I), or a pharmaceutically acceptable acid or base addition salt, a stereoisomer, or an N-oxide thereof, wherein R1 is not H, and is -V1-M1, R2 is H, R3 is -V2-M2, M1 and M2 are each selected from H or optionally substituted cycloalkyl, aryl, or heteroaryl, and wherein the other substituents are as defined in the specification. Also disclosed is the use of the compound for treating diseases related to the neuromodulatory effect of mGluR2 positive allosteric modulators.
Patent NZ-562314-A (NZ)
Title: Compounds which inhibit beta-secretase activity and methods of use thereof
Inventor: GHOSH ARUN K
IPC: C07D213/40
Filed: 2006-04-10
Abstract: Provided are memapsin beta-secretase inhibitors, including N1-(3-hydroxy-4-(4-methoxyphenylsulfonamido)-1-phenylbutan-2-yl)-5-(N-methylmethylsulfonamido)-N3-(1-phenylethyI)isophthalamide and related compounds. The compounds are useful for treating AlzheimerÆs disease and for reducing memapsin 2 catalytic activity.
Patent NZ-564148-A (NZ)
Title: A process for continuous carbonylation by supported ionic liquid-phase catalysis
Inventor: RIISAGER ANDERS
IPC: B01J31/20
Filed: 2006-05-19
Abstract: Disclosed is a process for the continuous carbonylation of carbonylatable products with carbon monoxide in the gaseous phase in the presence of a catalyst, wherein said catalyst is a Supported Ionic Liquid-Phase (SILP) catalyst comprising a solution of a Group VIII metal in an ionic liquid confined on a support.
Patent NZ-564722-A (NZ)
Title: Hinge for smoke alarm permits easy detachment for servicing
Inventor: KELLY DAVID
IPC: G08B17/10
Filed: 2007-12-21
Abstract: A smoke alarm has a body 1 mounting the smoke detector and battery B and a mounting plate 2 to mount the body and in turn to be attached to a surface such as a ceiling. The body is connectable to the mounting plate by a releasable latch 14, 15 on one side and a plastics hinge 12 on the other so that the body can be pivoted away from the mounting plate when the latch is unlatched whilst being connected to the plate by the hinge. Moreover, at least one side of the hinge 16 is disengageably interengaged with the either the body or the mounting plate at 17, 19 so that the body of the alarm can be completely though replaceably detached A, B from the mounting plate. This enables easy access for servicing the alarm, in particular for changing the battery B.
Patent NZ-565959-A (NZ)
Title: Pancreatin micropellet cores suitable for enteric coating
Inventor: SHLIEOUT GEORGE
IPC: A61K9/36
Filed: 2006-08-15
Abstract: Disclosed is a process for the manufacture of pancreatin micropellet cores, comprising the steps of: a. preparing an extrudable mixture comprising: i. 10 percent to 95 percent pancreatin; ii. 5 percent to 90 percent of at least one pharmaceutically acceptable binding agent selected from the group consisting of: polyethylene glycol 1500, polyethylene glycol 2000, polyethylene glycol 3000, polyethylene glycol 4000, polyethylene glycol 6000, polyethylene glycol 8000, polyethylene glycol 10000, hydroxypropyl methylcellulose, polyoxyethylene, copolymers of polyoxyethylene-polyoxypropylene and mixtures of said organic polymers; and iii. one or more enzyme-friendly organic solvents in an amount sufficient to form an extrudable mixture; wherein the percentages of components are weight to weight of the pancreatin micropellet cores and the constituents i.) and ii.) add to 100 percent by weight; b. extruding the extrudable mixture to create pancreatin micropellet cores; c. forming the pancreatin micropellet cores into approximately spherical or approximately ellipsoidal shape in the presence of additional enzyme-friendly organic solvent; and d. removing the one or more enzyme-friendly organic solvents from the pancreatin micropellet cores such that the pancreatin micropellet cores are substantially free of the one or more enzyme-friendly organic solvents; wherein the pancreatin micropellet cores are substantially free of synthetic oils. Also disclosed is the pancreatin micropellet obtained by the above process and a pharmaceutical composition comprising a pancreatin pellet made by the above process and the use of the micropellet for the preparation of a medicament for treating cystic fibrosis, digestive orders, pancreatic exocrine insufficiency, pancreatitis and diabetes.
Patent NZ-571092-A (NZ)
Title: Method and composition for treating chronic obstructive pulmonary disease
Inventor: UENO RYUJI
IPC: A61K31/5575
Filed: 2007-02-27
Abstract: Disclosed are bicyclic compounds of formula (I) including its pharmaceutically acceptable salts, ethers, esters, amides or tautomers, wherein A1 and A2 are halogen atoms and B is -COOH, and their use in treating chronic obstructive pulmonary disease (COPD).
Patent NZ-572565-A (NZ)
Title: Modified humanised anti-interleukin-18 antibodies
Inventor: ELLIS JONATHAN HENRY
IPC: A61P37/06
Filed: 2007-05-23
Abstract: Disclosed is a humanised anti-interleukin-18 antibody comprising CDRs derived from donor 2CI0 antibody grafted onto a human acceptor framework for treating autoimmune diseases. Also disclosed is a method for the production of the antibody.
Patent NZ-576195-A (NZ)
Title: Complement inhibition for improved nerve regeneration
Inventor: BAAS FRANK
IPC: A61P25/00
Filed: 2007-10-10
Abstract: Disclosed are medicaments used for treating conditions that require axonal regeneration, e.g. in mammals affected by injury or disease of the central or peripheral nervous system. The medicaments used in these methods facilitate axonal regeneration by inhibition of the complement system. Conditions requiring axonal regeneration that may be treated in accordance with the invention include physical injuries as well as neurodegenerative disorders of the peripheral or central nervous system.
Patent NZ-577663-A (NZ)
Title: System for coupling a drape to a microscope lens housing
Inventor: DILLON MARK S
IPC: A61B19/08
Filed: 2007-12-13
Abstract: A microscope drape disposable lens cover system includes a coupling member (202) configured to couple, to an objective lens barrel of a microscope. A lens housing (200) is coupled to the coupling member. The lens housing includes a transparent protective lens positioned such that a geometric normal of the protective lens forms an angle with respect to an optical axis of an objective lens housed within the objective lens barrel when the housing is coupled to the objective lens barrel. The protective lens includes a tab (236) for facilitating the removal and replacement of protective lens from the housing, the tab being formed integral to and from the same material as the protective lens. At least a portion of a fitting is disposed between the coupling member and the lens housing. The fitting (204) is frictionally retained adjacent the coupling member to prevent the rotation of the fitting relative to the coupling member but enables the rotation of lens housing with respect to the objective lens barrel coupling member.
Patent NZ-578218-A (NZ)
Title: An internal orbit, variable ratio continuous centrifugal grinding mill with a stationary feed-in system
Inventor: TURNER JOHN CHARLES
IPC: B02C17/08
Filed: 2009-07-07
Abstract: An internal orbit, variable ratio, continuous centrifugal grinding mill system (11) is disclosed. The centrifugal grinding mill (11) comprises a supporting framework (14), a main rotor (5), a grinding chamber (6), a main rotor drive system, a secondary rotor drive system, a grinding chamber in-feed system (7) and a grinding chamber discharge system (23). The main rotor (5) is supported within bearing arrangements (18, 19) by the supporting framework. The grinding chamber is a secondary, substantially tubular rotor supported and carried by the main rotor (5) to form a rotor assembly and has an axis of rotation substantially parallel to the axis of rotation of the main rotor. The axis of rotation of the main rotor (5) lies within the locus formed by the outer extremity of the secondary rotor as it rotates about its axis. The main rotor (5) and the secondary rotor can rotate continuously and independently about their respective axes of rotation. The main rotor drive system powers the rotation of the main rotor (5) and the secondary rotor drive system powers the rotation of the secondary rotor independently of the rotation of the main rotor (5). At least one in-feed opening in one end of the secondary rotor allows grinding furnish and/or grinding media to be admitted to the secondary rotor. At least one discharge port in the secondary rotor allows ground material to be extracted from the secondary rotor. The centrifugal grinding mill (11) is intended to be operated in a continuous manner. Internal profiling of the grinding chamber (6) is also disclosed to alter the grinding energy density as in different regions of the chamber (6).
Patent NZ-585191-A (NZ)
Title: Method of hydrothermal liquid phase sintering of ceramic materials and products derived therefrom
Inventor: RIMAN RICHARD E
IPC: C04B41/45
Filed: 2008-11-14
Abstract: 585181 Disclosed is a method of producing a monolithic body from a porous matrix, comprising: (i) forming a porous matrix having a shape and size and having interstitial spaces, wherein the porous matrix comprises at least a first reactant; (ii) providing the porous matrix having interstitial spaces; (iii) contacting the porous matrix with an infiltrating medium that carries at least a second reactant; (iv) allowing the infiltrating medium to infiltrate at least a portion of the interstitial spaces of the porous matrix under conditions that promote a reaction between the at least first reactant and the at least second reactant carried by the infiltrating medium to provide at least a first product, wherein a reaction temperature is less than about 250 DEGREE C; and (v) allowing the at least first product to form and fill at least a portion of the interstitial spaces of the porous matrix, thereby producing a monolithic body retaining substantially the same shape and size as the porous matrix, wherein the first product does not comprise barium titanate, wherein step (v) further comprises aging the monolithic body.
Patent NZ-587969-A (NZ)
Title: Clean production method of vanadium oxide
Inventor: PENG YI
IPC: C01G31/02
Filed: 2009-10-29
Abstract: Disclosed is a production method of vanadium oxide, comprising the following steps: a. mixing vanadium-containing material with additive to give mixed material, wherein the additive is CaO or limestone, and the amount of the additive makes the CaO/V2O5 weight ratio in the mixed material be 0.5-1.4 : 1; b. roasting the mixed material at 860 degree C-950 degree C in oxidizing atmosphere for 60-240min to give roasted material; c. adding water into the roasted material to give slurry, stirring, and slowly adding sulphuric acid solution to leach the slurry while controlling pH at 2.5-3.5; d. removing residue after leaching to give leachate, subjecting the leachate to P-removal treatment to make weight ratio of total V to P in the leachate 1000, washing the residue with circulation water to give washing water useful for preparing slurry in next leaching; e. adding ammonium salt in the P-removed leachate to make weight ratio of NH3/Mn in the leachate be 0.3-3.0 : 1, regulating pH of the solution with sulfuric acid to 1.5-2.5, heating to a temperature between 90 degree C and boiling temperature, holding at the temperature for 30-120min, filtering, and washing and drying the precipitate to give ammonium polyvanadate; f. subjecting the ammonium polyvanadate to calcination to remove ammonia to give V2O5, or reducing the ammonium polyvanadate to give V2O3; and g. removing P, Mn, and Mg impurities in the wastewater generated in step e to make Mn2+ and Mg2+ concentrations lower than 5g/L respectively, and P concentration lower than 0.005g/L to give circulation water, and returning the circulation water to step c for preparing slurry and to step d for washing the residue, wherein the solid raw material used in the above steps has total alkali metal amount not more than 0.3weight percentage, and total amount of Cl- and NO3 - not more than 0.1 weight percentage; and the liquid raw material used in the above steps has total alkali metal amount not more than 0.1 g/L, and total amount of Cl and NO3- not more than 0.1g/L.
Patent NZ-588308-A (NZ)
Title: Window and door frame assemblies with snap on architraves attached to frame elements from opposite sides of a wall panel
Inventor: HALL CHRIS
IPC: E06B1/04
Filed: 2010-09-29
Abstract: An assembly is disclosed for finishing the periphery of an opening (6, 10) in a stress skin wall panel (1). The assembly includes a first element (5, 8) which engages the opening (6, 10) in the panel via a first external side and includes a recess which receives an edge of the opening. The first element (5, 8) includes at least one surface fixable to the first side and a profile part which receives and retains a second element (7, 11) via snap fit engagement. The second element (7, 11) is a snap fit window or door architrave that engages an opposite internal surface of the stress skin panel (1). The first (5, 8) and second (7, 11) elements are fitted from opposite sides of the panel (1).
Patent NZ-589663-A (NZ)
Title: A device with a silver positive terminal and a negative terminal wherein a current is passed between the terminals which releases positive silver ions for use in reducing pathogenic microbes
Inventor: KUPPFER VALERIE
IPC: A61N1/30
Filed: 2009-05-28
Abstract: Disclosed is a device for reducing pathogenic microbes, comprising a hand grip, a negative terminal coming into contact with the body, and a device head with a positive terminal, wherein a low electrical voltage is generated in the device between the terminals, and wherein at least the positive terminal consists of silver, which releases positive ions into the body tissue upon closing the electric circuit.
Patent NZ-589758-A (NZ)
Title: Device for the preservation of a hepatic graft in normothermia utilising a preservation solution and a pressure and flow control device
Inventor: FONDEVILA CAMPO CONSTANTINO
IPC: A01N1/02
Filed: 2009-05-14
Abstract: 589758 Disclosed is a device for the preservation of a hepatic graft (1) in normothermia comprising a receptacle (2) in which the hepatic graft (1) is housed in a preservation solution, an arterial perfusion circuit (3), a portal perfusion circuit (5), at least one flow sensor (7) of a perfusion circuit, and at least one pressure sensor (8) of a perfusion circuit. For the purpose of increasing the preservation of the hepatic graft (1), the preservation device additionally comprises an arterial oxygenator (11) connected to the arterial perfusion circuit (3), a portal oxygenator (12) connected to the portal perfusion circuit (5), at least one arterial perfusion pump (9), at least one portal perfusion pump (10), a temperature exchange module (13) configured to maintain the temperature inside the receptacle (2) in normothermia, and a pressure and flow control device (14).
Patent NZ-592132-A (NZ)
Title: Composition comprising nanoparticles of docitaxel and a citrate
Inventor: DE TAPAS
IPC: A61K9/00
Filed: 2006-08-30
Abstract: Disclosed is a composition comprising nanoparticles comprising docetaxel and a citrate, wherein the stability of the composition is enhanced as compared to that of a composition without the citrate. The composition may additionally comprise a biocompatible polymer such as albumin. The composition is useful for treating cancer, such as prostate cancer, colon cancer, breast cancer, head and neck cancer, pancreatic cancer, lung cancer, and ovarian cancer.
Patent NZ-592652-A (NZ)
Title: Modular, portable dialysis system
Inventor: FULKERSON BARRY N
IPC: B01D61/24
Filed: 2009-10-30
Abstract: 592652 A dialysis unit that is modular and portable, with improved functionality. The dialysis system comprises a top controller unit (201) that is detachably affixed to a base (202) that comprises a reservoir (222) for fluid storage. The portable, modular dialysis system has improved power door locking, zoned leak detection, fluid handling, and mechanical design features that enable improved modularity.
Patent NZ-593629-A (NZ)
Title: Stable amorphous R-lansoprazole prepared by optically resolving racemic lansoprazole
Inventor: BHANU MANJUNATH NARAYAN
IPC: C07D401/12
Filed: 2008-12-18
Abstract: Disclosed is a stable amorphous R-(+)-lansoprazole prepared by optically resolving racemic lansoprazole by forming a reversible host-guest inclusion complex that includes a chiral guest molecule in the lansoprazole lattice comprising the following steps: (a) treating racemic lansoprazole with R-(+)-2,2'-dihydroxy-l,1'binaphthyl ("R-(+)-BINOL") in a suitable solvent to form the inclusion complex of R-(+)-lansoprazole with R-(+)-BINOL;(b) removing the inclusion complex of R-(+)-lansoprazole with R(+)-BINOL prepared in step (a) from the solvent and adding a mixture of organic solvents; (c) crystallizing the R-(+)-lansoprazole - R-(+)-BINOL inclusion complex from the mixture of organic solvents; (d) enriching the R-(+)-lansoprazole - R-(+)-BINOL inclusion complex to obtain a purity of more than about 97% e.e.; (e) cleaving the enriched R-(+)-lansoprazole - R-(+)-BINOL inclusion complex; (f) separating the R-BINOL and R-(+)-lansoprazole; and (g) isolating the R-(+)-lansoprazole.
Patent NZ-599299-A (NZ)
Title: Whey protein concentrate, its preparation and its use
Inventor: THIESSEN-BOLDER SUZANNE GODELIEVE
IPC: A23L13/60
Filed: 2010-10-11
Abstract: Disclosed is a process for manufacturing whey protein concentrate (WPC) from whey, said process involving a. providing acidified whey; b. increasing the pH of said acidified whey using one or more carbonate salt(s), preceded and/or followed by ultrafiltration, and c. subjecting the ultrafiltered carbonate-containing whey to spray drying.
Patent NZ-610710-A (NZ)
Title: Dual chamber prefillable syringe and aripiprazole filled in syringe
Inventor: KAKIUCHI MAKOTO
IPC: A61M5/28
Filed: 2011-11-16
Abstract: Disclosed is a two-chambered syringe (100) that allows a medicament of aripiprazole and solvent to be mixed before injecting to provide complete dissolution and avoid leaving a residue after discharge. The syringe is provided with: an outer tube (10) having a bypass part (11); a hub luer-lock aripiprazole and solvent are mixed before injecting(20); a front stopper (30); a middle stopper (40) that, along with the front stopper (30), seals the pharmaceutical preparation (S); an end stopper (50), that, along with the middle stopper (40), seals the liquid drug (L); a finger grip (60); and a plunger rod (70) that is connected to the end stopper (50) from the rearward end; wherein a female screw part (64) that twists around the axis line is formed on the inner circumferential surface of the finger grip (60) and a male screw part (73) capable of engaging with the female screw part (64) is formed on the outer circumferential surface of the plunger rod (70).
Patent NZ-611514-A (NZ)
Title: A process for the production of methacrylic acid and its derivatives and polymers produced therefrom
Inventor: JOHNSON DAVID WILLIAM
IPC: C08L33/06
Filed: 2011-11-18
Abstract: Disclosed is a process for the production of methacrylic acid. The process comprises the base catalysed decarboxylation of at least one or a mixture of dicarboxylic acids selected from itaconic, citraconic or mesaconic acid. The decarboxylation is carried out in the temperature range greater than 240 and up to 275°C to provide high selectivity. The methacrylic acid product may be esterified to produce an ester. A method of preparing polymers or copolymers of methacrylic acid or methacrylic acid esters using the process is also described. Optionally, the process may be preceded with a decarboxylation and, if necessary, a dehydration step on a source of pre-acid such as citric acid or isocitric acid.
Patent NZ-612338-A (NZ)
Title: Bottom preventer for use in a drilling system
Inventor: HARTUNG MARKUS
IPC: E21B19/16
Filed: 2011-11-28
Abstract: A conduit assembly for use in a drilling system is disclosed. The assembly includes an upper section (124), an intermediate section (123) and a lower section (122). The upper section includes a first seal (126). The first seal includes an opening that is sized and configured to receive and form a seal with an inner drill string (106). The first seal includes one or more slits that extend from an outer edge of the first seal to the opening of the first seal. The intermediate section includes an outlet (136) for a flushing medium. The outlet includes a projection (137) that extends into the interior of the intermediate section. The lower section is sized and configured to be connected to and disconnected from a connecting portion of an outer drill string (108). The lower section is sized and configured to be connected to and disconnected from the intermediate section.The lower section may be sized and configured to be connected to and disconnected from a connecting portion of an outer drill string. The lower portion of the conduit assembly is sized and configured to engage a clamp when the lower portion of the conduit assembly is connected to the outer drill string to prevent a loss of the outer drill string down a borehole.
Patent NZ-616256-A (NZ)
Title: Absorption medium and method for absorption of an acid gas from a gas mixture
Inventor: LENORMANT THIBAUT
IPC: F23J15/04
Filed: 2012-05-25
Abstract: Disclosed herein is an absorption medium which comprises water, a 4-amino-2,2,6,6-tetramethylpiperidineamine compound (A) of the formula (I) where R is a n-alkyl radical having 1 to 4 carbon atoms, and an alkanolamine (B) which is a tertiary amine or a sterically hindered primary or secondary amine selected from the group consisting of N-methyldiethanolamine or 2-amino-2-methyl-1-propanol. The disclosed absorption medium has a high absorption capacity for carbon dioxide (CO2) at a high absorption rate and is used to absorb CO2 from gas mixtures such as a synthesis gas, a natural gas or a combustion off-gas without a separation of the absorption medium into two liquid phases or the precipitation of a solid during the absorption of CO2.
Patent NZ-618405-A (NZ)
Title: Fermentation of fruit juices
Inventor: MACDONALD ALAN CAMERON
IPC: C12G1/02
Filed: 2012-10-05
Abstract: Discloses a method of introducing yeast into a fruit juice such as grape must to be fermented. The method comprises feeding dry yeast into a flowing stream of the fruit juice and delivering the flowing stream of fruit juice with the yeast in it to a mixer. The fruit juice and yeast emerging from the mixer is fed into a fermentation tank. The yeast can include nutrients selected from inactivated yeasts, yeast autolysates, yeast cell hulls, yeast extracts, amino acids, peptides, proteins, sterols, ergosterol, thiamin, biotin, pantothenic acid, niacin, riboflavin, pyridoxine, minerals and inorganic nitrogen in the form of ammonium salts.